These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 1316067

  • 1. Quinolone pharmacokinetics in the elderly.
    Schentag JJ, Goss TF.
    Am J Med; 1992 Apr 06; 92(4A):33S-37S. PubMed ID: 1316067
    [Abstract] [Full Text] [Related]

  • 2. Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones.
    Blum RA.
    Am J Med; 1992 Apr 06; 92(4A):18S-21S. PubMed ID: 1316065
    [Abstract] [Full Text] [Related]

  • 3. Single-dose pharmacokinetics of lomefloxacin in patients with normal and impaired renal function.
    Nilsen OG, Saltvedt E, Walstad RA, Marstein S.
    Am J Med; 1992 Apr 06; 92(4A):38S-40S. PubMed ID: 1316068
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of lomefloxacin in renally compromised patients.
    Blum RA, Schultz RW, Schentag JJ.
    Antimicrob Agents Chemother; 1990 Dec 06; 34(12):2364-8. PubMed ID: 2088191
    [Abstract] [Full Text] [Related]

  • 5. Quinolones in the aged.
    Nicolle LE.
    Drugs; 1999 Dec 06; 58 Suppl 2():49-51. PubMed ID: 10553705
    [Abstract] [Full Text] [Related]

  • 6. Quinolone disposition in the elderly. Practical implications.
    Nilsson-Ehle I, Ljungberg B.
    Drugs Aging; 1991 Dec 06; 1(4):279-88. PubMed ID: 1794020
    [Abstract] [Full Text] [Related]

  • 7. Comparative study of pharmacokinetics of two new fluoroquinolones, balofloxacin and grepafloxacin, in elderly subjects.
    Kozawa O, Uematsu T, Matsuno H, Niwa M, Nagashima S, Kanamaru M.
    Antimicrob Agents Chemother; 1996 Dec 06; 40(12):2824-8. PubMed ID: 9124849
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of lomefloxacin in patients with cirrhosis.
    Lebrec D, Gaudin C, Benhamou JP.
    Am J Med; 1992 Apr 06; 92(4A):41S-44S. PubMed ID: 1316069
    [Abstract] [Full Text] [Related]

  • 9. Lomefloxacin clinical pharmacokinetics.
    Freeman CD, Nicolau DP, Belliveau PP, Nightingale CH.
    Clin Pharmacokinet; 1993 Jul 06; 25(1):6-19. PubMed ID: 8394795
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of fluorinated 4-quinolones in the aged.
    Norrby SR, Ljungberg B.
    Rev Infect Dis; 1989 Jul 06; 11 Suppl 5():S1102-6. PubMed ID: 2672244
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of temafloxacin in patients with liver impairment.
    Granneman GR, Mahr G, Locke C, Nickel P, Kirch W, Fabian W, Kinzig M, Naber KG, Sörgel F.
    Clin Pharmacokinet; 1992 Jul 06; 22 Suppl 1():24-32. PubMed ID: 1319868
    [Abstract] [Full Text] [Related]

  • 17. [Comparative pharmacokinetics of lomefloxacin and other fluoroquinolones].
    Iakovlev VP.
    Antibiot Khimioter; 1998 Jul 06; 43(10):46-52. PubMed ID: 9825111
    [No Abstract] [Full Text] [Related]

  • 18. Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.
    Sorgel F, Naber KG, Kinzig M, Mahr G, Muth P.
    Am J Med; 1991 Dec 30; 91(6A):51S-66S. PubMed ID: 1662896
    [Abstract] [Full Text] [Related]

  • 19. Temafloxacin pharmacokinetics in subjects with normal and impaired renal function.
    Granneman GR, Braeckman R, Kraut J, Shupien S, Craft JC.
    Antimicrob Agents Chemother; 1991 Nov 30; 35(11):2345-51. PubMed ID: 1666497
    [Abstract] [Full Text] [Related]

  • 20. Fluoroquinolones in the elderly: safety considerations.
    Stahlmann R, Lode H.
    Drugs Aging; 2003 Nov 30; 20(4):289-302. PubMed ID: 12641485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.